Last reviewed · How we verify

Std-dose iv MgSO4

Hamad Medical Corporation · Phase 3 active Small molecule

Magnesium sulfate acts as an anticonvulsant and vasodilator by inhibiting neuronal excitability and promoting blood vessel dilation.

Magnesium sulfate acts as an anticonvulsant and vasodilator by inhibiting neuronal excitability and promoting blood vessel dilation. Used for Pre-eclampsia prevention and treatment, Seizure prophylaxis in eclampsia.

At a glance

Generic nameStd-dose iv MgSO4
SponsorHamad Medical Corporation
Drug classAnticonvulsant, Vasodilator
TargetVoltage-gated calcium channels
ModalitySmall molecule
Therapeutic areaCardiovascular, Neurology
PhasePhase 3

Mechanism of action

Magnesium sulfate's anticonvulsant properties are thought to be due to its ability to block voltage-gated calcium channels, reducing neuronal excitability and preventing seizures. Its vasodilatory effects are mediated through the relaxation of smooth muscle cells in blood vessels, leading to increased blood flow and decreased blood pressure.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: